Abstract
After the publication [1] the authors report corrections for Table 3, for the headers of columns 5 and 7, which should read as follows: Column 5 Header: P-value for pCR, T vs Other Arms in HR+, and Column 7 Header: P-value for pCR, T vs Other Arms in HR-. The correct version of the table can be found below. (Table presented).
Cite
CITATION STYLE
Jacobs, S. A., Robidoux, A., Abraham, J., Pérez-Garcia, J. M., La Verde, N., Orcutt, J. M., … Pogue-Geile, K. L. (2020, January 22). Correction: NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer (Breast Cancer Research (2019) 21 (133) DOI: 10.1186/s13058-019-1196-y). Breast Cancer Research. BioMed Central Ltd. https://doi.org/10.1186/s13058-019-1240-y
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
